Stock exchanges
Johnson & Johnson Reports Third Quarter Earnings and Announces Plan to Separate Orthopaedics Business
Johnson & Johnson (JNJ) released its third quarter earnings report on October 14, 2025, announcing sales of $52.1 billion and earnings per share (EPS) of $2.10. The company's Orthopaedics business is expected to be separated, with a press release announcing the plan dated October 14, 2025.